Insights

Filters   Sort By Newest  
Newest Oldest Title
Updating results

Showing results 1 - 24 of 107 Results per page:

No results found.

  • Advertising, Marketing & Regulatory
  • Artificial Intelligence
  • Automotive
  • Cannabis
  • Chemical
  • Chemical AI
  • Cleantech
  • Copyright & Digital Media
  • Electrical & Computer Technology
  • Financial Technology
  • Industrial Designs
  • IP Management & Strategic Counselling
  • Licensing & Transactions
  • Life Sciences
  • Litigation & Contentious IP
  • Mechanical & Industrial Processes
  • Medical Technology
  • Nanotechnology
  • Oil & Gas
  • Patents
  • Plant Breeders’ Rights
  • Privacy & Data Protection
  • Psychedelics
  • Quantum Technologies
  • Trademarks
  • Nicholas Aitken
  • Arvin Angue
  • Adam Aucoin
  • William Audet
  • Ryan Baker
  • Christie J. C. Bates
  • Stephen Beney
  • Brett Benham
  • Daniel Bereskin, C.M., K.C.
  • Janice M. Bereskin
  • Shaivi Bhatt
  • Adam Bierylo
  • Paul David Blizzard
  • Adam Bobker
  • Chantalle Briggs
  • Jonathan G. Burkinshaw
  • Isi Caulder
  • Brigitte Chan
  • Wynnie Chan
  • Mina Chana
  • Herman Cheung
  • Kyle Classen
  • Toba Cooper
  • Noel Courage
  • Carmela De Luca
  • Ryan De Vries
  • Reshika Dhir
  • Meghan Dillon
  • Michael Fenwick
  • Patricia Folkins
  • Cameron Gale
  • Matthew John Graff
  • Louis-Pierre Gravelle
  • Micheline Gravelle
  • Gail Hung
  • Nicole Hunter
  • Jason Hynes
  • Alissa Hyppolite
  • Ellen Kiernan
  • Simone Knott
  • Ray Kovarik
  • Chris Kowal
  • Victor Krichker
  • Dominique Lambert
  • François Larose
  • Julia London
  • Maddie Lynch
  • Joanna Ma
  • Alfred A. Macchione
  • R. Scott MacKendrick
  • Don MacOdrum
  • Sandra Marone
  • Andrew McIntosh
  • Melissa J. McKeon
  • Ian McMillan
  • Philip C. Mendes da Costa
  • David Morrison
  • Luba Naiberger
  • Paige Newman
  • Andrea Ngo
  • Tony Orsi
  • Ainslie Parsons
  • Moïse Perreault
  • Justin Philpott
  • Scott Pundsack
  • James Raakman
  • Bhupinder Randhawa
  • Sunil Rao
  • Mark L. Robbins
  • Jane Sarjeant
  • Timothy Sinnott
  • Parnian Soltanipanah
  • Josh Spicer
  • David St-Martin
  • Kate Stewart-Tiralongo
  • Robert Storey
  • Jessica R. Sudbury
  • Melanie Szweras
  • Andrea Uetrecht
  • Charles Wang
  • Maria Wei
  • Tamara Céline Winegust
  • Leanne Young
  • Jennie Yum
  • Previous 30 days
  • Previous 90 days
  • Previous year
  • From to

Explore our Insights

October 31, 2023
Unveiling the Gaps: Year One of CIHR’s Clinical Trial Registration Rules
By Maddie Lynch and Noel Courage
›
October 27, 2023
PMPRB Adopts Amended Interim Guidelines to Expedite New Patented Medicine Price Reviews
By Nyrie Israelian and Noel Courage
›
July 14, 2023
Elevate IP – New Canadian Funding Program to Elevate your IP Game
By Joanna Ma and Noel Courage
›
May 5, 2023
Intellectual Property Strategy for Protecting Software: Supplementing Utility Patent Protection with Industrial Designs
By Joanna Ma and Noel Courage
›
February 17, 2023
Global Trends in Battery Technology: A Patent Perspective
By: Nicole LaBerge, Nicholas Watermeyer[1], Noel Courage
›
February 15, 2023
2022 Year in Review: Life Sciences
By Luba Naiberger, Jessica R. Sudbury, and Noel Courage
›
January 10, 2023
Canadian Grant Agency Raises Clinical Trial Reporting Requirements
By Maddie Lynch and Noel Courage 
›
December 12, 2022
Getting Transparent About Transparency: Canadian Registration and Reporting of Clinical Trials
By Noel Courage and Maddie Lynch
›
December 2, 2022
The Role of IP Management in Product Development
By Luba Naiberger and Noel Courage 
›
November 10, 2022
PMPRB Regulations Saga Coming to an End? New Draft Guidelines Issued
By Nyrie Israelian, Parnian Soltanipanah, Melanie Szweras, Noel Courage 
›
August 26, 2022
Is this Drug Safe and Effective Enough? Canadian Regulators Wade into Alzheimer’s Drug Controversy
By Noel Courage and Iris Cheung
›
June 27, 2022
One person’s trash is another person’s treasure – Where France goes, will others follow?
By Noel Courage and Luca Manfredi
›

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

May 5, 2022
What’s it Worth? Valuation of IP
By Noel Courage and Keon Coleman
›
April 22, 2022
Canada Drops its Most Controversial Patented Drug Pricing Amendments
By Nyrie Israelian and Noel Courage
›
April 1, 2022
Supreme Court of Canada Takes a Pass on Patented Drug Price Dispute
By: Nyrie Israelian and Noel Courage
›
March 18, 2022
Ontario Government Launches IP Agency to Support Innovators and Increase IP Value
By: Mitchel Fleming, Tony Orsi and Noel Courage
›
March 9, 2022
2021 Year in Review: COVID-19
By Noel Courage and Herman Cheung
›
February 28, 2022
Proposed Canadian Drug Pricing Rules Delayed by Feds and Battered by Courts 
By Noel Courage and Nyrie Israelian
›
December 9, 2021
Plot Twist: New Exceptions Water Down Ban on Employee Non-Compete Agreements
By Noel Courage
›
November 25, 2021
Licensing of COVID-19 Diagnostic IP to Facilitate Fast Access in the Third World  
By Noel Courage
›
November 17, 2021
Medicines Patent Pool Gets Big Wins in Accessing Breakthrough COVID-19 Drugs for the Third World
By Noel Courage 
›
November 16, 2021
One Person’s Trash is Another Person’s Treasure Part IV: The Right to Repair Movement – U.K. Update
By Bonnie Hassanzadeh and Noel Courage
›
November 9, 2021
A Healthy Dose of Skepticism From Regulators Leads to a Safe and Effective Dose of COVID-19 Drugs and Vaccines
By Noel Courage and Iris Cheung
›
October 26, 2021
Use of Employee Non-compete Agreements About to Become Void in Ontario
By Noel Courage
›
Loading...
Load Results 25 - 48 of 107

Showing results 1 - 24 of 107 Results per page:

No results found.

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This site is registered on wpml.org as a development site.